简体中文 | 繁體中文 | English

Health and Pharmaceutical Press Releases

2024-10-21 13:22 ASDS 2024: New Phase III READY-4 Data Demonstrate Long-Term Safety and Efficacy of Galderma’s RelabotulinumtoxinA (Relfydess™)
2024-10-18 10:27 Celltrion presents 2-year post-hoc analysis findings for subcutaneous infliximab (CT-P13 SC), highlighting dose escalation as an option for managing loss of response in inflammatory bowel disease
2024-10-18 09:42 Medidata Announces Rave Lite to Support Growth in Early and Late-Stage Clinical Trials
2024-10-17 10:11 Myrobalan Therapeutics Strengthens Board of Directors with Appointment of Emma Reeve
2024-10-16 16:06 Aster Guardians Global Nursing Award Announces Top 10 Finalists for 2024
2024-10-16 16:03 Novotech Earns Great Place to Work® Certification in the United States
2024-10-15 09:29 Invisalign® Palatal Expander System by Align Technology Now Available in Hong Kong for Skeletal and Dental Expansion in Growing Patients
2024-10-10 11:28 Kewpie Confirms Improved Ease of Eating Vegetables and Other Foods Through Adding Mayonnaise or Emulsified Dressings
2024-10-10 11:19 Avania Buys Spanish MedTech CRO Anagram to Enhance Its Core CRO Offering in a New European Geography
2024-10-10 11:14 EU Notified Body (BSI Netherlands) and the EMA Grant Approval of the LeukoStrat® CDx FLT3 Mutation Assay for VANFLYTA® Therapy in the EU and EEA
2024-10-09 15:17 JT Group Completes Acquisition of Vector Group Ltd.
2024-10-09 11:14 Novaliq and Laboratoires Théa Announce Partnership and EU Approval for Vevizye® (Ciclosporin 0.1% Eye Drops Solution)
2024-10-09 09:59 Ferring Pharmaceuticals bolsters global gene therapy supply chain with European manufacturing facility
2024-10-09 09:30 CAI Appoints Sheena Dempsey as Chief Executive Officer
2024-10-08 16:16 Crown Bioscience Expands Singapore Facility with Advanced Oncology Models and Imaging Capabilities
2024-10-08 15:57 Cancer Therapy: AOP Health Investigates a New Approach Targeting Cancer Stem Cells
2024-10-08 14:56 Ferring Demonstrates Effectiveness of a Treat-to-Target Approach in Mild-to-Moderate Ulcerative Colitis in First Major Study
2024-10-08 11:51 Primary Endpoint Met in Phase 3 Comparative Clinical Study of Perjeta® (pertuzumab) Biosimilar Candidate HLX11
2024-09-27 14:49 Global Oncology Innovator BeiGene Appoints Shalini Sharp to Board of Directors
2024-09-26 13:50 Medidata Extends Its Commitment to the Patient Experience with the Launch of Patient Payments

Business Wire Weibo

Press Releases

Latest Releases